olmesartan medoxomil and hydrochlorothiazide

Generic: olmesartan medoxomil and hydrochlorothiazide

Labeler: lifestar pharma llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name olmesartan medoxomil and hydrochlorothiazide
Generic Name olmesartan medoxomil and hydrochlorothiazide
Labeler lifestar pharma llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

hydrochlorothiazide 12.5 mg/1, olmesartan medoxomil 40 mg/1

Manufacturer
Lifestar Pharma LLC

Identifiers & Regulatory

Product NDC 70756-813
Product ID 70756-813_45806c19-480f-987e-e063-6394a90aa8fa
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA208847
Listing Expiration 2026-12-31
Marketing Start 2020-10-01

Pharmacologic Class

Established (EPC)
thiazide diuretic [epc]
Chemical Structure
thiazides [cs]
Physiologic Effect
increased diuresis [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 70756813
Hyphenated Format 70756-813

Supplemental Identifiers

RxCUI
403853 403854 403855
UPC
0370756814122
UNII
0J48LPH2TH 6M97XTV3HD
NUI
N0000175359 N0000175419 M0471776

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name olmesartan medoxomil and hydrochlorothiazide (source: ndc)
Generic Name olmesartan medoxomil and hydrochlorothiazide (source: ndc)
Application Number ANDA208847 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 12.5 mg/1
  • 40 mg/1
source: ndc
Packaging
  • 1000 TABLET in 1 BOTTLE (70756-813-12)
  • 30 TABLET in 1 BOTTLE (70756-813-30)
  • 500 TABLET in 1 BOTTLE (70756-813-51)
  • 90 TABLET in 1 BOTTLE (70756-813-90)
source: ndc

Packages (4)

Ingredients (2)

hydrochlorothiazide (12.5 mg/1) olmesartan medoxomil (40 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "45806c19-480f-987e-e063-6394a90aa8fa", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "upc": ["0370756814122"], "unii": ["0J48LPH2TH", "6M97XTV3HD"], "rxcui": ["403853", "403854", "403855"], "spl_set_id": ["9771066e-c05d-6a93-e053-2995a90a7e87"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["Lifestar Pharma LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1000 TABLET in 1 BOTTLE (70756-813-12)", "package_ndc": "70756-813-12", "marketing_start_date": "20201001"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (70756-813-30)", "package_ndc": "70756-813-30", "marketing_start_date": "20201001"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (70756-813-51)", "package_ndc": "70756-813-51", "marketing_start_date": "20201001"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (70756-813-90)", "package_ndc": "70756-813-90", "marketing_start_date": "20201001"}], "brand_name": "Olmesartan Medoxomil and Hydrochlorothiazide", "product_id": "70756-813_45806c19-480f-987e-e063-6394a90aa8fa", "dosage_form": "TABLET", "pharm_class": ["Angiotensin 2 Receptor Antagonists [MoA]", "Angiotensin 2 Receptor Blocker [EPC]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "70756-813", "generic_name": "Olmesartan Medoxomil and Hydrochlorothiazide", "labeler_name": "Lifestar Pharma LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Olmesartan Medoxomil and Hydrochlorothiazide", "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "12.5 mg/1"}, {"name": "OLMESARTAN MEDOXOMIL", "strength": "40 mg/1"}], "application_number": "ANDA208847", "marketing_category": "ANDA", "marketing_start_date": "20201001", "listing_expiration_date": "20261231"}